IVERIC BIO INC's ticker is ISEE and the CUSIP is 46583P102. A total of 225 filers reported holding IVERIC BIO INC in Q1 2023. The put-call ratio across all filers is 0.58 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $9,268 | -75.3% | 235,648 | -84.7% | 0.01% | -64.7% |
| Q1 2023 | $37,531 | +648.5% | 1,542,570 | +558.8% | 0.02% | +750.0% |
| Q4 2022 | $5,014 | -99.9% | 234,152 | -29.2% | 0.00% | -66.7% |
| Q3 2022 | $5,930,000 | +4228.5% | 330,550 | +2216.1% | 0.01% | – |
| Q2 2022 | $137,000 | -97.9% | 14,272 | -96.3% | 0.00% | -100.0% |
| Q1 2022 | $6,490,000 | +34.1% | 385,639 | +33.3% | 0.01% | +400.0% |
| Q4 2021 | $4,838,000 | +593.1% | 289,290 | +572.4% | 0.00% | – |
| Q3 2021 | $698,000 | +28.3% | 43,023 | -50.2% | 0.00% | – |
| Q2 2021 | $544,000 | +29.8% | 86,393 | +27.3% | 0.00% | – |
| Q1 2021 | $419,000 | -8.9% | 67,887 | +2.0% | 0.00% | – |
| Q4 2020 | $460,000 | +121.2% | 66,556 | +81.0% | 0.00% | – |
| Q3 2020 | $208,000 | +63.8% | 36,771 | +47.9% | 0.00% | – |
| Q2 2020 | $127,000 | – | 24,866 | +2486500.0% | 0.00% | – |
| Q4 2019 | $0 | – | 1 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TCG Crossover Management, LLC | 5,141,118 | $110,071,336 | 19.43% |
| Deep Track Capital, LP | 7,878,119 | $168,670,528 | 7.08% |
| Soleus Capital Management, L.P. | 2,114,728 | $45,276,326 | 6.50% |
| MPM BioImpact LLC | 1,059,688 | $22,687,920 | 5.89% |
| Finepoint Capital LP | 707,600 | $15,150 | 4.90% |
| ACUTA CAPITAL PARTNERS, LLC | 360,500 | $7,718,305 | 4.75% |
| Octagon Capital Advisors LP | 1,278,000 | $27,361,980 | 4.26% |
| Artia Global Partners LP | 504,615 | $10,803,807 | 4.12% |
| Ghost Tree Capital, LLC | 450,000 | $9,635,000 | 4.11% |
| Redmile Group, LLC | 4,502,111 | $96,390,197 | 3.94% |